International Variation in Prostate Cancer Incidence and Mortality Rates

Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Lyon, France: International Agency for Research on Cancer; 2010.

Platz, 2006, Prostate cancer, 1128

Ferlay, 2010, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int J Cancer, 127, 2893, 10.1002/ijc.25516

Ferlay J, Parkin DM, Curado MP, et al. Cancer incidence in five continents, volumes I to IX: IARC CancerBase No. 9. Lyon, France: International Agency for Research on Cancer. World Health Organization Web site. http://ci5.iarc.fr.

Surveillance Epidemiology and End Results (SEER) Program. National Cancer Institute Web site. http://seer.cancer.gov/.

Actualités [in French]. Institut de Veille Sanitaire Web site. http://www.invs.sante.fr/. Accessed July 2009.

AIHW home page. Australian Institute of Health and Welfare Web site. http://www.aihw.gov.au.

Most recent data. Croatian National Cancer Registry Web site. http://www.hzjz.hr/cancer/recent.htm.

Aktuality, zpravodajství [in Czech]. Epidemiologie Zhoubných Nádorů v České Republice [National Cancer Registry of the Czech Republic] Web site. http://www.svod.cz/.

NORDCAN - on the Web. Association of the Nordic Cancer Registries Web site. http://www.ancr.nu.

Home page. The National Cancer Registry Ireland Web site. http://www.ncri.ie/.

National cancer registry [in Hebrew]. Ministry of Health Israel Web site. http://www.health.gov.il/.

National cancer registry [in Nederlander]. Integraal Kankercentrum Nederland Web site. http://www.iknl.nl.

Home page. New Zealand Ministry of Health Web site. http://www.health.govt.nz/.

National Health Information Centre [in Slovak]. http://www.nczisk.sk.

Home page [in Slovenian]. Institute of Oncology Ljubljana Web site. http://www.onko-i.si/.

N. Ireland Cancer Registry. Queens University Belfast Web site. http://www.qub.ac.uk/research-centres/nicr/.

Information Services Division (ISD). ISD Scotland Web site. http://www.isdscotland.org/.

Welsh Cancer Intelligence and Surveillance Unit (WCISU). NHS Wales Web site. http://www.wales.nhs.uk/sites3/home.cfm?OrgID=242.

Publication hub: gateway to UK National Statistics. UK National Statistics Web site. http://www.statistics.gov.uk.

Parkin, 2010, Fifty years of cancer incidence: CI5 I-IX, Int J Cancer, 127, 2918, 10.1002/ijc.25517

WHO mortality database: tables. World Health Organization WHO Statistical Information System http://www.who.int/whosis/mort/download/en/index.html.

Kim, 2000, Permutation tests for joinpoint regression with applications to cancer rates, Stat Med, 19, 335, 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z

Clegg, 2009, Estimating average annual per cent change in trend analysis, Stat Med, 28, 3670, 10.1002/sim.3733

Segi, 1960

Doll R, Payne P, Waterhouse JAH. Cancer incidence in five continents. Vol 1. Geneva, Switzerland: Union Internationale Contre le Cancer; 1966.

Kvale, 2007, Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries, J Natl Cancer Inst, 99, 1881, 10.1093/jnci/djm249

Baade, 2009, International epidemiology of prostate cancer: geographical distribution and secular trends, Mol Nutr Food Res, 53, 171, 10.1002/mnfr.200700511

Potosky, 1995, The role of increasing detection in the rising incidence of prostate cancer, JAMA, 273, 548, 10.1001/jama.1995.03520310046028

Catalona, 1994, Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men, J Urol, 151, 1283, 10.1016/S0022-5347(17)35233-3

Potosky, 1990, Rise in prostatic cancer incidence associated with increased use of transurethral resection, J Natl Cancer Inst, 82, 1624, 10.1093/jnci/82.20.1624

Draisma, 2009, Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context, J Natl Cancer Inst, 101, 374, 10.1093/jnci/djp001

Etzioni, 2002, Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends, J Natl Cancer Inst, 94, 981, 10.1093/jnci/94.13.981

Hayes, 1999, Dietary factors and risks for prostate cancer among blacks and whites in the United States, Cancer Epidemiol Biomarkers Prev, 8, 25

Whittemore, 1995, Prostate cancer in relation to diet, physical activity, and body size in blacks, whites, and Asians in the United States and Canada, J Natl Cancer Inst, 87, 652, 10.1093/jnci/87.9.652

Rose, 1986, International comparisons of mortality rates for cancer of the breast, ovary, prostate, and colon, and per capita food consumption, Cancer, 58, 2363, 10.1002/1097-0142(19861201)58:11<2363::AID-CNCR2820581102>3.0.CO;2-#

Siegel, 2011, Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths, CA Cancer J Clin, 61, 212, 10.3322/caac.20121

Bunker, 2002, High prevalence of screening-detected prostate cancer among Afro-Caribbeans: the Tobago Prostate Cancer Survey, Cancer Epidemiol Biomarkers Prev, 11, 726

Glover, 1998, The epidemiology of prostate cancer in Jamaica, J Urol, 159, 1984, 10.1016/S0022-5347(01)63220-8

Kohler, 2011, Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system, J Natl Cancer Inst, 103, 714, 10.1093/jnci/djr077

Haiman, 2007, Multiple regions within 8q24 independently affect risk for prostate cancer, Nat Genet, 39, 638, 10.1038/ng2015

Okobia, 2011, Chromosome 8q24 variants are associated with prostate cancer risk in a high risk population of African ancestry, Prostate, 71, 1054, 10.1002/pros.21320

Haiman, 2011, Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21, Nat Genet, 43, 570, 10.1038/ng.839

Fedewa, 2010, Association of insurance and race/ethnicity with disease severity among men diagnosed with prostate cancer, National Cancer Database 2004–2006, Cancer Epidemiol Biomarkers Prev, 19, 2437, 10.1158/1055-9965.EPI-10-0299

Bray, 2010, Prostate cancer incidence and mortality trends in 37 European countries: an overview, Eur J Cancer, 46, 3040, 10.1016/j.ejca.2010.09.013

Melia, 2004, Rates of prostate-specific antigen testing in general practice in England and Wales in asymptomatic and symptomatic patients: a cross-sectional study, BJU Int, 94, 51, 10.1111/j.1464-4096.2004.04832.x

Hsing, 2000, International trends and patterns of prostate cancer incidence and mortality, Int J Cancer, 85, 60, 10.1002/(SICI)1097-0215(20000101)85:1<60::AID-IJC11>3.0.CO;2-B

Parkin, 2010, Changing cancer incidence in Kampala, Uganda, 1991–2006, Int J Cancer, 126, 1187, 10.1002/ijc.24838

Collin, 2008, Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study, Lancet Oncol, 9, 445, 10.1016/S1470-2045(08)70104-9

Etzioni, 2008, Quantifying the role of PSA screening in the US prostate cancer mortality decline, Cancer Causes Control, 19, 175, 10.1007/s10552-007-9083-8

Walsh, 1998, Anatomic radical prostatectomy: evolution of the surgical technique, J Urol, 160, 2418, 10.1016/S0022-5347(01)62202-X

Peschel, 2003, Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer, Lancet Oncol, 4, 233, 10.1016/S1470-2045(03)01035-0

Baade, 2004, International trends in prostate-cancer mortality: the decrease is continuing and spreading, Cancer Causes Control, 15, 237, 10.1023/B:CACO.0000024212.66334.26

Gavin, 2004, Evidence of prostate cancer screening in a UK region, BJU Int, 93, 730, 10.1111/j.1464-410X.2003.04716.x

Andriole, 2009, Mortality results from a randomized prostate-cancer screening trial, N Engl J Med, 360, 1310, 10.1056/NEJMoa0810696

Schroder, 2009, Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, 360, 1320, 10.1056/NEJMoa0810084

Schröder, 2010, ERSPC and PLCO prostate cancer screening studies: what are the differences?, Eur Urol, 58, 46, 10.1016/j.eururo.2010.03.033

Parkin, 2006, International patterns of cancer incidence and mortality, 101

Clegg, 2002, Impact of reporting delay and reporting error on cancer incidence rates and trends, J Natl Cancer Inst, 94, 1537, 10.1093/jnci/94.20.1537